FOXO TECHNOLOGIES INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
FOXO TECHNOLOGIES INC. (FOXO) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $718.00 thousand for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-12.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2022-08-12
- FOXO TECHNOLOGIES INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2022-06-30 was $224.00K.
- FOXO TECHNOLOGIES INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2022-03-31 was $494.00K, a 52.95% decline year-over-year.
- FOXO TECHNOLOGIES INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2021-12-31 was $110.00K.
- FOXO TECHNOLOGIES INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2021-09-30 was -$592.00K.
- FOXO TECHNOLOGIES INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $268.00K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 6 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 8 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 8 month as first filed | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 9 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|---|---|---|---|---|
| 2022-06-30 | $224.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $718.00K 10-Q · filed 2022-08-12 | $828.00K derived: sum of 3 quarters · filed 2022-08-12 | $236.00K derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2022-03-31 | $494.00K 10-Q · filed 2022-05-16 | $604.00K derived: sum of 2 quarters · filed 2022-05-16 | $12.00K derived: sum of 3 quarters · filed 2022-05-16 | -$288.00K derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2021-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | -$482.00K derived: sum of 2 quarters · filed 2022-03-07 | -$782.00K derived: sum of 3 quarters · filed 2022-03-07 | $268.00K 10-K · filed 2022-03-07 | ||
| 2021-09-30 | -$592.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$892.00K derived: sum of 2 quarters · filed 2021-11-15 | $158.00K 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | -$300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $750.00K 10-Q · filed 2021-08-16 | ||||
| 2021-03-31 | $1.05M 10-Q · filed 2021-05-17 | |||||
| 2020-12-31 | -$375.00K 10-K/A · filed 2021-05-17 | -$8.00K 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |